Phase II study of modified nab-paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable advanced pancreatic cancer
Not Applicable
Recruiting
- Conditions
- The unresectable advanced pancreatic cancer in elderly patients over 75 years
- Registration Number
- JPRN-UMIN000038738
- Lead Sponsor
- Aichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with contraindication of nab-Paclitaxel+Gemcitabine 2) Second primary malignancy 3) Any patients judged by the investigator to be unfit to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method